Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Public ClinicalTrials.gov record NCT02616562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Multinational, Active-controlled, (Open-labelled), Dose Finding, (Double-blinded), Parallel Group Trial Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of once-weekly NNC0195-0092 treatment compared to daily growth hormone treatment (Norditropin® FlexPro®) in growth hormone treatment naïve pre-pubertal children with growth hormone deficiency. The main trial period will consist of 26 weeks of treatment, followed by a 26 week extension period.
Study identification
- NCT ID
- NCT02616562
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 76 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 2 Years to 10 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2016 (Actual)
- Primary completion
- Sep 26, 2024 (Actual)
- Completion
- Sep 26, 2024 (Actual)
- Last update posted
- Jan 16, 2026
2016 – 2024
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's of Alabama | Birmingham | Alabama | 35233 | — |
| Children's Hospital Los Angeles - Endocrinology | Los Angeles | California | 90027 | — |
| Mattel Children's Hospital at UCLA | Los Angeles | California | 90095 | — |
| Valley Children's Hospital | Madera | California | 93636-8762 | — |
| Novo Nordisk Clinical Trial Call Center | San Diego | California | 92123 | — |
| The Regents of the Univ of CA | San Diego | California | 92123 | — |
| Rocky Mt Ped and Endo | Centennial | Colorado | 80112 | — |
| Ped Endo Assoc PC-G.V | Greenwood Village | Colorado | 80111-2803 | — |
| Nemours/AI duPont Hosp-Chld | Wilmington | Delaware | 19803 | — |
| The Endocrine Center | Pembroke Pines | Florida | 33028 | — |
| Childrens Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Riley Hospital For Children | Indianapolis | Indiana | 46202 | — |
| Novo Nordisk Clinical Trial Call Center | Minneapolis | Minnesota | 55454 | — |
| University of Minnesota_Minneapolis_2 | Minneapolis | Minnesota | 55454 | — |
| Goryeb Children's Hospital | Morristown | New Jersey | 07962 | — |
| Novo Nordisk Clinical Trial Call Center | Morristown | New Jersey | 07962 | — |
| Rutgers-Rwjms | New Brunswick | New Jersey | 08901 | — |
| UBMD Peds-Div of Endo/Diabetes | Buffalo | New York | 14203 | — |
| Novo Nordisk Clinical Trial Call Center | Mineola | New York | 11501 | — |
| NYU Langone Hospital-LI | Mineola | New York | 11501 | — |
| CCHMC_Cinc | Cincinnati | Ohio | 45229 | — |
| Novo Nordisk Clinical Trial Call Center | Cincinnati | Ohio | 45229 | — |
| University Of Oklahoma-Tulsa | Tulsa | Oklahoma | 74135 | — |
| Dell Pediatric Research Institute | Austin | Texas | 78723 | — |
| Endocrine Associates Of Dallas | Plano | Texas | 75093 | — |
| Children's Hsptl Of The Kings | Norfolk | Virginia | 23507 | — |
| MultiCare Inst for Res & Innov | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02616562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 16, 2026 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02616562 live on ClinicalTrials.gov.